NO306508B1 - Benzopyraner og beslektede LTB4 antagonister - Google Patents

Benzopyraner og beslektede LTB4 antagonister

Info

Publication number
NO306508B1
NO306508B1 NO942759A NO942759A NO306508B1 NO 306508 B1 NO306508 B1 NO 306508B1 NO 942759 A NO942759 A NO 942759A NO 942759 A NO942759 A NO 942759A NO 306508 B1 NO306508 B1 NO 306508B1
Authority
NO
Norway
Prior art keywords
benzopyrans
ltb4 antagonists
related ltb4
antagonists
ltb4
Prior art date
Application number
NO942759A
Other languages
English (en)
Norwegian (no)
Other versions
NO942759L (no
NO942759D0 (no
Inventor
Kevin Koch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO942759L publication Critical patent/NO942759L/no
Publication of NO942759D0 publication Critical patent/NO942759D0/no
Publication of NO306508B1 publication Critical patent/NO306508B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO942759A 1992-01-23 1994-07-22 Benzopyraner og beslektede LTB4 antagonister NO306508B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82441292A 1992-01-23 1992-01-23
PCT/US1992/009496 WO1993015067A1 (fr) 1992-01-23 1992-11-13 Benzopyranne et antagonistes de ltb4 apparentes

Publications (3)

Publication Number Publication Date
NO942759L NO942759L (no) 1994-07-22
NO942759D0 NO942759D0 (no) 1994-07-22
NO306508B1 true NO306508B1 (no) 1999-11-15

Family

ID=25241346

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942759A NO306508B1 (no) 1992-01-23 1994-07-22 Benzopyraner og beslektede LTB4 antagonister

Country Status (37)

Country Link
US (2) US5552435A (fr)
EP (1) EP0623123B1 (fr)
JP (1) JP2765757B2 (fr)
KR (2) KR0124802B1 (fr)
CN (1) CN1041311C (fr)
AP (1) AP352A (fr)
AT (1) ATE152108T1 (fr)
AU (1) AU666896B2 (fr)
BG (1) BG62331B1 (fr)
BR (1) BR9207061A (fr)
CA (1) CA2126752C (fr)
CZ (1) CZ282400B6 (fr)
DE (1) DE69219364T2 (fr)
DK (1) DK0623123T3 (fr)
EG (1) EG20202A (fr)
FI (1) FI943474A (fr)
GR (1) GR3023657T3 (fr)
HK (1) HK1000245A1 (fr)
HU (1) HU221194B1 (fr)
IL (1) IL104386A (fr)
IS (1) IS1795B (fr)
MX (1) MX9300312A (fr)
MY (1) MY109144A (fr)
NO (1) NO306508B1 (fr)
NZ (1) NZ245735A (fr)
OA (1) OA11456A (fr)
PH (1) PH30346A (fr)
PL (1) PL171003B1 (fr)
PT (1) PT101183B (fr)
RO (1) RO112031B1 (fr)
RU (1) RU2114110C1 (fr)
SG (1) SG49813A1 (fr)
SK (1) SK280451B6 (fr)
TW (1) TW213907B (fr)
WO (1) WO1993015067A1 (fr)
YU (1) YU48949B (fr)
ZA (1) ZA93486B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2084547B1 (es) * 1993-07-12 1997-01-16 Pfizer Antagonistas benzopiranicos y relacionados de leucotrieno b4.
AU696890B2 (en) * 1994-10-13 1998-09-24 Pfizer Inc. Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists
CA2202056A1 (fr) * 1994-10-13 1996-04-25 Mark A. Dombroski Composes de benzopyranne et composes benzo-fusionnes, leur preparation et leur utilisation comme antagonistes du leucotriene b4' (ltb4)
SK31399A3 (en) * 1996-09-16 2000-05-16 Pfizer Processes and intermediates for preparing substituted chromanol derivatives
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
EP0836850A3 (fr) * 1996-10-17 2000-11-29 Pfizer Inc. Méthode pour prévenir le rejet d'allogreffes
EP0963755A3 (fr) * 1998-04-16 2001-03-14 Pfizer Products Inc. Utilisation des benzopyranes pour la prévention de rejets de graiffes
US6436987B1 (en) * 2000-06-08 2002-08-20 Pfizer Inc. Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid
WO2002036173A2 (fr) 2000-11-03 2002-05-10 Bristol-Myers Squibb Pharma Company Double imagerie isotopique simultanee d'une perfusion et d'une inflammation cardiaque
CA2433516A1 (fr) * 2001-01-30 2002-08-08 Keith Michael Devries Procedes de preparation d'acides chromanylbenzoiques
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
AU2005266088A1 (en) * 2004-07-22 2006-02-02 Pharmacia Corporation Compositions for treatment of inflammation and pain using a combination of a COX-2 selective inhibitor and a LTB4 receptor antagonist
US10336733B2 (en) 2015-11-30 2019-07-02 Merk Sharp & Dohme Corp. Aryl acylsulfonamides as BLT1 antagonists
EP3383389B1 (fr) * 2015-11-30 2021-04-28 Merck Sharp & Dohme Corp. Utilisation d'arylacylsulfonamides en tant qu'antagonistes de blt1
US10450309B2 (en) 2015-11-30 2019-10-22 Merch Sharp & Dohme Corp. Aryl sulfonamides as BLT1 antagonists
EP3383868B1 (fr) 2015-11-30 2022-10-05 Merck Sharp & Dohme LLC Sulfonamides d'aryle utilisés en tant qu'antagonistes de blt1

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2309282A1 (de) * 1973-02-24 1974-08-29 Hoechst Ag Verfahren zur herstellung von 4-hydroxy-thiochromanen
DE2745305A1 (de) * 1977-10-07 1979-04-19 Bayer Ag Insektizide und akarizide mittel
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (fr) * 1987-01-12 1993-07-20 Darrel M. Gapinski Agents antiinflammatoires
JPS63292977A (ja) * 1987-05-25 1988-11-30 片山 晋 スキ−用のビンディング固定板
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
MX13485A (es) * 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
WO1990012010A1 (fr) * 1989-04-07 1990-10-18 Pfizer Inc. Chromans substitues pour le traitement de l'asthme, de l'arthrite et de maladies apparentees
WO1990015801A1 (fr) * 1989-06-22 1990-12-27 Pfizer Inc. Sulfamides substitues et composes apparentes dans le traitement de l'asthme, de l'arthrite et des maladies apparentees
WO1991012253A1 (fr) * 1990-02-07 1991-08-22 Pfizer Inc. Derives de tetraline et de chroman utilises dans le traitement de l'asthme, de l'arthrite et de maladies apparentees
DK0623122T3 (da) * 1992-01-23 1997-04-21 Pfizer Benzopyran og beslægtede LTB4-antagonister
EP0558245A1 (fr) * 1992-02-25 1993-09-01 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Composés hétérobicycliques comme antagonistes des récepteurs alpha-1 adrénergiques et 5HT1A
FR2693196B1 (fr) * 1992-07-03 1994-12-23 Lipha Dérivés de benzopyranone ou de benzothiopyranone, procédé de préparation et composition pharmaceutique les contenant.

Also Published As

Publication number Publication date
US5552435A (en) 1996-09-03
WO1993015067A1 (fr) 1993-08-05
KR0124802B1 (ko) 1997-11-25
PT101183B (pt) 1999-09-30
DE69219364T2 (de) 1997-08-07
HUT68790A (en) 1995-07-28
JPH07502536A (ja) 1995-03-16
AU3065092A (en) 1993-09-01
IL104386A0 (en) 1993-05-13
CA2126752A1 (fr) 1993-08-05
ZA93486B (en) 1994-07-22
AP9200449A0 (en) 1993-01-31
PT101183A (pt) 1994-03-31
IS1795B (is) 2001-12-18
EP0623123B1 (fr) 1997-04-23
CN1041311C (zh) 1998-12-23
MY109144A (en) 1996-12-31
BR9207061A (pt) 1995-12-26
PL171003B1 (pl) 1997-02-28
HU221194B1 (en) 2002-08-28
CZ176294A3 (en) 1995-02-15
US5684046A (en) 1997-11-04
ATE152108T1 (de) 1997-05-15
TW213907B (fr) 1993-10-01
NO942759L (no) 1994-07-22
SG49813A1 (en) 1998-06-15
RU94035964A (ru) 1997-05-27
CN1075318A (zh) 1993-08-18
DK0623123T3 (da) 1997-10-13
EG20202A (en) 1997-10-30
OA11456A (en) 2003-11-18
FI943474A0 (fi) 1994-07-22
YU3393A (sh) 1996-07-24
SK280451B6 (sk) 2000-02-14
RU2114110C1 (ru) 1998-06-27
BG98867A (bg) 1995-03-31
HK1000245A1 (en) 1998-02-13
MX9300312A (es) 1993-07-31
AP352A (en) 1994-08-10
CZ282400B6 (cs) 1997-07-16
RO112031B1 (ro) 1997-04-30
PH30346A (en) 1997-04-02
SK84494A3 (en) 1995-05-10
BG62331B1 (bg) 1999-08-31
YU48949B (sh) 2003-01-31
GR3023657T3 (en) 1997-09-30
HU9401979D0 (en) 1994-09-28
IL104386A (en) 2001-05-20
FI943474A (fi) 1994-07-22
KR950700273A (ko) 1995-01-16
NO942759D0 (no) 1994-07-22
CA2126752C (fr) 2000-05-16
NZ245735A (en) 1995-04-27
AU666896B2 (en) 1996-02-29
IS3969A (is) 1993-07-24
EP0623123A1 (fr) 1994-11-09
JP2765757B2 (ja) 1998-06-18
DE69219364D1 (de) 1997-05-28

Similar Documents

Publication Publication Date Title
NO942758D0 (no) Benzopyraner og beslektede LTB4 antagonister
DE59208263D1 (de) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate
NO942759L (no) Benzopyraner og beslektede LTB4 antagonister
FI910116A (fi) sigma-delta-modulator foer d/a-omvandlare
NO922934D0 (no) Cykloheksan- og tetrahydropyranderivater
BR9205281A (pt) Pentapeptideos imuno-reguladores e neuro-reguladores
FI1031U1 (fi) En troakar
ITMI921571A1 (it) Azaciclo e azabiciclo alchiliden idrossilamine
NO305649B1 (no) Silot°mmeanordning
FI925468A (fi) Kinolylmetoxifenylaettiksyraacylamider och -ureor
DE69226430D1 (de) Fungizide 4-thioxooxazolidin-2-one und 4-iminooxazolidin-2-one
ZA93483B (en) Benzopyrans and related ltb antagonists
KR940007037U (ko) 캔 온장고
ATE149330T1 (de) Handgelenkorthese
ES1022279Y (es) Muneca
KR930002787U (ko) 구축용 조립블록
FI925090A0 (fi) Stallarakenne
NO924377D0 (no) Beskyttende konstruksjon
BR9203039A (pt) Soutien reversivel

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees